Former health-care executive Kay Wagoner, Ph.D., has joined the Eshelman Institute for Innovation as associate director for innovation and entrepreneurship. Wagoner is also life science executive in residence in the UNC-Chapel Hill Office of Commercialization and Economic Development, an EIR … Continued

In a rapid-fire series of breakthroughs in just under a year, researchers at the UNC Eshelman School of Pharmacy have made another stunning advance in the development of an effective glioblastoma treatment for a common and aggressive brain cancer. The … Continued

A new project led by researchers at RENCI and the UNC Eshelman School of Pharmacy aims to develop a biomedical data “translator” that will integrate, synthesize and interpret multiple sources of clinical and biomedical data to provide information to guide clinical … Continued

The Carolina E(I) Lab, part of the Eshelman Institute for Innovation, concluded its pilot year by hosting final presentations from the inaugural cohort of student teams on Oct. 1, with the top four teams awarded monetary prizes. The presentations were … Continued

Triangle-area high school students who participated in the first summer of the Young Innovators Program at the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill worked in research labs, thought critically about pharmacy practice, … Continued

Roy Zwahlen, J.D., has joined the UNC Eshelman School of Pharmacy as assistant dean for innovation and strategy. Zwahlen’s first responsibility is to assist the dean in formulating, interpreting and implementing policy at the School. “Because the UNC Eshelman School … Continued

Jerry Heneghan, M.B.A., delivered the keynote address at this year’s Serious Play Conference, hosted by the UNC Kenan-Flagler Business School from July 25-28. Global thought leaders in the field of serious games and simulations descended on the University of North … Continued

Researchers at the University of North Carolina at Chapel Hill seeking a better treatment for glioblastoma have discovered that removing a brain tumor causes any cancer left behind to grow 75 percent faster than the original tumor did, which helps … Continued

Mucommune, LLC is the fourth company spun out of the research enterprise at the UNC Eshelman School of Pharmacy to take up residence in the Eshelman Institute for Innovation MicroIncubator located at the School. Mucommune was born in 2015 from … Continued

UNC Eshelman School of Pharmacy held a press event on Wednesday, March 30, to celebrate its number one ranking by U.S. News & World Report in the 2017 edition of America’s Best Graduate Schools. Chancellor Carol L. Folt, Ph.D., hosted … Continued